Scottish Investment Bank and Innovate UK were among those backing University of Strathclyde brain cancer diagnosis spinout ClinSpec Diagnostics.

The Eli Lilly and Mitsui-backed drug developer has received $11m in a round led by Cell Innovation Partners, taking its overall funding to more than $83m.

Taikang Life Insurance backed a $14.8m round for the online medical data platform, which already counts Fosun, DXY and Meituan Dianping as shareholders.

908 Devices plans to add a life science device to its chemical detection product range, having landed $17.5m in a Schlumberger and Saudi Aramco-backed round.

Telus Ventures is set to exit healthcare data management software producer Get Real Health in an $11m purchase by CPSI, six years after it invested.

The 12-week medtech and digital health accelerator is also being supported by medical care provider Hartford HealthCare and will onboard its first ten startups in June 2019.

Sohaib Mir has earned a promotion to principal having joined Cambridge Innovation Capital to provide business expertise in the life science space in 2014.

MRCF has reached the first close of a CSL-backed fifth fund to make early-stage investments in medical technologies in Australia and New Zealand.

Digital China Health Technologies chipped into the third tranche of a round featuring fellow corporates BGI Genomics and Healthlink that now tops $30m.

The CIC-backed clinical genomics platform operator took its series B round to $30.1m following a $17.1m extension that will fund the development of automation and statistical analysis functionality.